DuPont de Nemours, Inc.
Edward D Breen (Director) sells DD shares
About this filing
DuPont de Nemours, Inc. (DD) filed Form 4 (insider transaction) with the SEC on Nov 9, 2026. Form 4 reports a company insider’s trades in the company’s shares.
Key facts
- Insider
- Edward D Breen · Director
| Date | Transaction | Shares | Price | Value | Held after | Ownership |
|---|---|---|---|---|---|---|
| Aug 28, 2026 | G · giftFootnotes F1, F2 | +35,551 | $0.00 | $0.00 | 127,275.5715 | Direct |
| Nov 5, 2026 | M · exercise or conversion of a derivative | +89,845 | $108.84 | $9,778,729.80 | 217,120.5715 | Direct |
| Nov 5, 2026 | S · open-market saleFootnotes F3 | −89,845 | $146.41 | $13,154,206.45 | 127,275.5715 | Direct |
| Nov 5, 2026 | M · exercise or conversion of a derivativeStock Options (Right to Buy NQOs)Footnotes F4 | +89,845 | $0.00 | $0.00 | 0 | Direct |
Footnotes
- F1 Represents annuity payment back to Mr. Breen from 2024 GRAT 9.
- F2 Includes acquisition of shares pursuant to dividend reinvestment.
- F3 Weighted average sales price of $146.4176. Trades ranged from $144.04 to $149.28. Upon request, the reporting person will provide to the Commission, the issuer and any stockholder full information regarding the number of shares that were sold at each separate price.
- F4 Options become exercisable in three substantially equal installments beginning on the first anniversary of the grant, option shares may be used to satisfy withholding taxes.
More DD filings
- SC 13G
Filed Nov 10, 2026
- 4
Filed Nov 9, 2026
- 4
Filed Nov 9, 2026
- 144
Filed Nov 9, 2026
- 144
Filed Nov 9, 2026
- 144
Filed Nov 5, 2026
Not investment advice. Summaries can contain errors; the SEC filing is the official record.